Загрузка...
Experience with Vildagliptin in Patients ≥75 Years with Type 2 Diabetes and Moderate or Severe Renal Impairment
INTRODUCTION: Patients with type 2 diabetes (T2DM) are at increased risk for renal impairment (RI) and, in addition, there is an age-related decline in renal function. At the same time, T2DM treatment is more complex and treatment options are more limited in elderly patients as well as patients with...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3889331/ https://ncbi.nlm.nih.gov/pubmed/23821355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-013-0027-x |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|